TY - JOUR
T1 - Inflammatory cytokines as a third signal for T cell activation
AU - Curtsinger, Julie M.
AU - Mescher, Matthew F.
N1 - Funding Information:
The work summarized here from our laboratory was supported by National Institutes of Health Grants RO1 AI34824 and PO1AI35296 .
PY - 2010/6
Y1 - 2010/6
N2 - CD8 T cells require a third signal, along with Ag and costimulation, to make a productive response and avoid death and/or tolerance induction. Recent studies indicate that IL-12 and Type I IFN (IFNα/β) are the major sources of signal 3 in a variety of responses, and that the two cytokines stimulate a common regulatory program involving altered expression of about 350 genes. Signal 3-driven chromatin remodeling is likely to play a major role in this regulation. Although less well studied, there is emerging evidence that CD4 T cells may also require a 'third signal' for a productive response and that IL-1 can provide this signal. Signal 3 cytokines can replace adjuvants in supporting in vivo T cell responses to peptide and protein antigens, and a better understanding of their activities and mechanisms should contribute to more rational design of vaccines.
AB - CD8 T cells require a third signal, along with Ag and costimulation, to make a productive response and avoid death and/or tolerance induction. Recent studies indicate that IL-12 and Type I IFN (IFNα/β) are the major sources of signal 3 in a variety of responses, and that the two cytokines stimulate a common regulatory program involving altered expression of about 350 genes. Signal 3-driven chromatin remodeling is likely to play a major role in this regulation. Although less well studied, there is emerging evidence that CD4 T cells may also require a 'third signal' for a productive response and that IL-1 can provide this signal. Signal 3 cytokines can replace adjuvants in supporting in vivo T cell responses to peptide and protein antigens, and a better understanding of their activities and mechanisms should contribute to more rational design of vaccines.
UR - http://www.scopus.com/inward/record.url?scp=77953541634&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953541634&partnerID=8YFLogxK
U2 - 10.1016/j.coi.2010.02.013
DO - 10.1016/j.coi.2010.02.013
M3 - Review article
C2 - 20363604
AN - SCOPUS:77953541634
SN - 0952-7915
VL - 22
SP - 333
EP - 340
JO - Current Opinion in Immunology
JF - Current Opinion in Immunology
IS - 3
ER -